This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Regentis International, Université De Reims Champagne-Ardenne. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2015
Title: Sandrine Lorimier: Innovator in Bifunctional Peptides
Introduction
Sandrine Lorimier is a notable inventor based in Reims, France. She has made significant contributions to the field of biochemistry, particularly in the development of innovative peptides that have applications in cosmetics and pharmaceuticals. Her work focuses on enhancing collagen synthesis and inhibiting harmful proteases.
Latest Patents
Sandrine holds 1 patent for her invention of a bifunctional peptide. This peptide is designed to activate collagen synthesis while simultaneously inhibiting the production of matrix metallo-proteinases. The structure of the peptide includes three distinct parts: part A, a hexapeptide that stimulates collagen synthesis; part B, a tetrapeptide that acts as a competitive inhibitor of urokinase protease; and part C, a tripeptide that occupies active sites of matrix metallo-proteinases to inhibit their activity. This invention also encompasses a cosmetic and/or pharmaceutical composition that incorporates the bifunctional peptide.
Career Highlights
Throughout her career, Sandrine has worked with various organizations, including Regentis International and Université De Reims Champagne-Ardenne. Her research and innovations have contributed to advancements in the field of peptide technology.
Collaborations
Sandrine has collaborated with notable professionals in her field, including William Hornebeck and Joan Attia. These collaborations have further enriched her research and development efforts.
Conclusion
Sandrine Lorimier is a pioneering inventor whose work on bifunctional peptides has the potential to revolutionize cosmetic and pharmaceutical applications. Her contributions to the field are significant and continue to inspire further research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile